Skip to main content
logo
Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
6.84
-0.04 (-0.60%)
May 8, 2026, 12:25 PM EDT - Market open

Fulcrum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
456753254418379719
Market Cap Growth
135.15%196.87%-39.31%10.19%-47.23%119.65%
Enterprise Value
139.65404.7419.07190.34187.18500.52
Last Close Price
6.8411.314.706.757.2817.69
PE Ratio
--9.58-29.37-4.25-2.98-7.72
PS Ratio
--3.17148.9959.8037.50
PB Ratio
1.372.161.041.781.913.40
P/TBV Ratio
1.372.051.201.761.652.96
P/FCF Ratio
--12.47-101.62-4.57-3.83-8.96
P/OCF Ratio
--12.54-114.36-4.59-3.91-9.16
EV/Sales Ratio
--0.2467.8629.5126.12
EV/EBITDA Ratio
--4.85-0.94-1.75-1.70-6.37
EV/EBIT Ratio
--4.77-0.87-1.72-1.66-6.18
EV/FCF Ratio
--6.70-7.64-2.08-1.89-6.24
Debt / Equity Ratio
0.010.010.030.040.050
Debt / EBITDA Ratio
-0.07-0.08-0.42-0.10-0.12-
Debt / FCF Ratio
-0.09-0.11-3.46-0.12-0.14-
Net Debt / Equity Ratio
-0.98-0.99-0.96-0.96-0.95-1.03
Net Debt / EBITDA Ratio
3.844.1511.452.081.722.78
Net Debt / FCF Ratio
5.135.7393.112.461.912.72
Asset Turnover
-00.310.010.030.11
Quick Ratio
33.7927.0022.0117.3112.1511.55
Current Ratio
34.3327.4022.6317.7112.4111.77
Return on Equity (ROE)
-22.31%-25.30%-4.07%-44.84%-53.53%-52.72%
Return on Assets (ROA)
-24.28%-27.04%-8.45%-45.69%-48.76%-44.46%
Return on Invested Capital (ROIC)
-1844.48%-1196.20%-210.25%-1076.24%-1680.77%-1992.48%
Return on Capital Employed (ROCE)
-25.08%-28.12%-8.87%-48.75%-52.88%-50.87%
Earnings Yield
-16.30%-10.43%-3.40%-23.56%-33.52%-12.95%
FCF Yield
-13.68%-8.02%-0.98%-21.89%-26.11%-11.16%
Buyback Yield / Dilution
-7.54%-2.21%-1.10%-36.27%-27.23%-39.47%
Total Shareholder Return
-7.54%-2.21%-1.10%-36.27%-27.23%-39.47%
Updated Apr 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q